Supernus Pharmaceuticals | SUPN - Market Capitalization

Stock Price
49.43
Daily Change
-1.77 -3.46%
Monthly
0.43%
Yearly
47.86%
Q2 Forecast
48.44

Supernus Pharmaceuticals reported $2.8B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
ANI Pharmaceuticals USD 1.69B 57M May/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Corcept Therapeutics USD 4.32B 654M Mar/2026
Eisai JPY 1.33T 22.44B May/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Novo Nordisk A/S DKK 1.45T 421.31B May/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.58B 265M May/2026
Pfizer USD 147.4B 6.42B May/2026
Supernus Pharmaceuticals USD 2.82B 155M May/2026
United Therapeutics USD 28.08B 2.9B May/2026
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025